Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × hCG × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 228 Neoplasms 168 Prostatic Neoplasms 99 Polycystic Ovary Syndrome 96 Colorectal Neoplasms 95 Carcinoma, Hepatocellular 87 Carcinoma, Non-Small-Cell Lung 74 Lung Neoplasms 59 Precursor Cell Lymphoblastic Leukemia-Lymphoma 54 Stomach Neoplasms 53 Pain 53 Neoplasm Metastasis 47 Multiple Myeloma 43 Pancreatic Neoplasms 42 Keratosis, Actinic 39 Pain, Postoperative 37 Head and Neck Neoplasms 35 Leukemia, Myeloid, Acute 34 Liver Neoplasms 33 Leiomyoma 33 Lymphoma 32 Colonic Neoplasms 32 Uterine Cervical Neoplasms 31 Recurrence 30 Papillomavirus Infections 29 Lymphoma, Follicular 28 Infertility 28 Brain Neoplasms 28 Anemia 28 Leukemia 27

Interventions

Chorionic Gonadotropin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03495609 2023-09-07

Use of Recombinant hCG to Prevent Breast Cancer in BRCA1 and BRCA2 Carriers

University Hospital, Ghent

Phase 4 Completed

hCG

Data powered by HemOnc (CC BY 4.0) Colophon ⚡